W. R. Grace & Co.-Conn is an API manufacturer based in United States. It holds 14 active US drug master files across a filed portfolio of 13 molecules. Its filings concentrate with EEC_EAEU and BRELA (TZ). Its GMP standing is certified by NAFDAC (NG) and US FDA. Its most recent recorded inspection, by US FDA, closed on 2 March 2026 as NAI.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| South Haven, United States | 1826582 |
| Molecule | Regulators | Docs |
|---|---|---|
| Lidocaine | US FDA | 2 |
| Benazepril | US FDA | 1 |
| Benzonatate | US FDA | 1 |
| Diphenhydramine | US FDA | 1 |
| Fenoprofen | US FDA | 1 |
| Itraconazole | US FDA | 1 |
| Milrinone | US FDA | 1 |
| Orphenadrine | US FDA | 1 |
| Pramocaine | US FDA | 1 |
| Procainamide | US FDA | 1 |
| Propranolol | US FDA | 1 |
| Terconazole | US FDA | 1 |
| Tetracaine | US FDA | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| EEC_EAEU | 2 | None |
| BRELA (TZ) | 1 | None |
| NAFDAC (NG) | None | 1 |
| US FDA | None | 1 |
Choose your molecules and target markets. W. R. Grace & Co.-Conn comes back tiered against every other supplier able to file there.
Start for free